Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 2 , ISSUE 4 ( October-December, 2018 ) > List of Articles

RESEARCH ARTICLE

Clinical Efficacy and Safety of Kushmandaka Rasayana in the Management of Chronic Bronchitis: A Prospective Open Label Multicenter Study

Kiran Kale, Prem Lal Bharati, Babita Yadav, MN Suryawanshi, Kshirod Kumar Ratha, Bhagwan Sahai Sharma

Keywords : FEV1%,Clinical COPD questionnaire,Kaphaja Kasa

Citation Information : Kale K, Bharati PL, Yadav B, Suryawanshi M, Ratha KK, Sharma BS. Clinical Efficacy and Safety of Kushmandaka Rasayana in the Management of Chronic Bronchitis: A Prospective Open Label Multicenter Study. J Res Ayurvedic Sci 2018; 2 (4):225-232.

DOI: 10.5005/jp-journals-10064-0062

License: CC BY-NC 4.0

Published Online: 00-00-0000

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Prevalence of chronic bronchitis is increasing as a part of urbanization and increased pollution. Failure of timely recognition of the condition often causes worsening of the disease. In Ayurveda, the symptoms of chronic bronchitis may be compared with those of Kaphaja Kasa. Kushmandaka Rasayana is a medicine that is commonly used in respiratory diseases owing to its Rasayana effect. Objectives: To evaluate the clinical efficacy and safety of Kushmandaka Rasayana in chronic bronchitis. Materials and methods: A prospective, open-label multicenter study was carried out in three peripheral centers of the Central Council for Research in Ayurvedic Sciences (CCRAS). A total of 193 patients with chronic bronchitis (Kaphaja Kasa) satisfying the selection criteria were enrolled from the outpatient department of these centers and were administered with 10 g of Kushmandaka Rasayana twice daily with lukewarm water for 12 weeks, and the patients were followed up, every two weeks up to the 12th week and at the 14th week (without medication follow-up). Changes in the symptoms, clinical COPD questionnaire (CCQ), and forced expiratory volume in the first second (FEV1%), were assessed every 14 days till 12 weeks and at the end of 14 weeks and were compared with baseline data. A p value of <0.05 was considered as significant. Safety assessment was done by analyzing liver function test (LFT) and renal function test (RFT) parameters before and after the trial. Result: Statistically significant improvement was observed in clinical symptoms, FEV1, and CCQ questionnaire without any adverse drug reactions (ADR)/adverse events (AE). All safety parameters were within normal limits during the entire trial.


PDF Share
  1. Kim V, Criner GJ. Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2013 Feb 01;187(3):228-237
  2. Australian Institute of Health and Welfare. Chronic respiratory diseases in Australia: their prevalence, consequences and prevention. PHE 63. Canberra: AIHW; 2005. p.4-6.
  3. Susruta, Susruta Samhita with Nibandhasangraha commentary of dalhanacharya, Yadavji Trikamji Acharya, editor, Uttarathantra-52/10. 6th ed. Varanasi: Chaukhambha Orientalia, p.767.
  4. Susruta Samhita of Susruta with Nibandhasangraha commentary of dalhanacharya, Yadavji Trikamji Acharya, editor, Ch. 52 Ver. 4, 6th ed. Varanasi: Chaukhambha Orientalia; p.767.
  5. Kim V, Criner GJ. Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2013 Feb 01;187(3)
  6. Acharya VJT, Samhita C, Sthana C. Ch. 17, shloka no. 89, Varanasi: Chaukhambha Surbharati Prakasana; 2008. p.537.
  7. Astanga Hridaya of Vagbhata with Sarvangasundari Vyakhya, Sri Lalchand Vaidya, editor, Chikitsasthana 3/113- 116, 1st ed. Motilal Banarasi Das; p.391.
  8. Bhaisajya Ratanavali of Shri Govinda Dasji, Bhisagratna Shri Brahmasankar Mishra, editor, Vol. 1, Ch. Raktapitta Chikitsadhikara, Ver. 110-123, 1st ed. Chaukhamba Sanskrt Samsthan; p.760.
  9. Astanga Hridaya of Vagbhata with commentaries of Arundatta & Hemadri, Chiktsasthana, Ch. 3, Ver. 114-117, 9th ed. Varanasi: Chaukhambha Orientaila; 2005. p.596.
  10. Astanga Hridaya of Vagbhata with commentaries of Arundatta & Hemadri, Sutrasthana, Ch. 6, Ver. 88, 9th ed. Varanasi: Chaukhambha Orientaila; 2005. p.104
  11. Charaka Samhita of Agnivesha with Ayurveda dipika commentary of Chakrapani, Chikitsasthana Ch. 27, Ver. 113, New Delhi: Rashtriya Ayurveda Sansthana; reprint 2005. p.159.
  12. Sushruta samhita of Sushruta, Sutrasthana Ch. 46. Ver. 211-214, reprint, Ambikadatta Shastri, editor, Varanasi: Chaukhamba Sanskrt Sansthan; 2007. p.202.
  13. Yoshizumia S, Murakami T, Kadoya M, et al. Medicinal food stuffs. XI. Histamine release inhibitors from wax gourd, fruits of Benincasa hispida Cogn. J Pharm Soc Jpn 1998;118(5):188-192.
  14. Benincasa hispida var, pruriens, Polynesian Wax Gourd, cited on 23rd October, 2011, available from http://www. articlesbase.com/alternative-medicine-articles/4478775
  15. Mananvalan G and Singh J. Chemical and some pharmacological studies on leaves of P.longum Linn. Indian J Pharm Sci. 1979;41:190
PDF Share